Spontaneous seizures and loss of axo-axonic and axo-somatic inhibition induced by repeated brief seizures in kindled rats.
Repeated brief seizures evoked by kindling progressively increase seizure susceptibility and eventually induce spontaneous seizures. Previous studies have demonstrated that the initial seizures evoked by kindling increase paired-pulse inhibition at 15-25 msec interpulse intervals in the dentate gyrus and also induce apoptosis, progressive neuronal loss, mossy fiber sprouting, and neurogenesis, which could potentially alter the balance of excitation and/or inhibition and modify functional properties of hippocampal circuits. In these experiments, paired-pulse inhibition in the dentate gyrus was reduced or lost after approximately 90-100 evoked seizures in association with emergence of spontaneous seizures. Evoked IPSCs examined by single electrode voltage-clamp methods in granule cells from kindled rats experiencing spontaneous seizures demonstrated altered kinetics (reductions of approximately 48% in 10-90% decay time, approximately 40% in tau, and approximately 65% in charge transfer) and confirmed that decreased inhibition contributed to the reduced paired-pulse inhibition. The loss of inhibition was accompanied by loss of subclasses of inhibitory interneurons labeled by cholecystokinin and the neuronal GABA transporter GAT-1, which project axo-somatic and axo-axonic GABAergic inhibitory terminals to granule cells and axon initial segments. Seizure-induced loss of interneurons providing axo-somatic and axo-axonic inhibition may regulate spike output to pyramidal neurons in CA3 and could play an important role in generation of spontaneous seizures. The sequence of progressive cellular alterations induced by repeated seizures, particularly loss of GABAergic interneurons providing axo-somatic and axo-axonic inhibition, may be important in the development of intractable epilepsy.
Sayin
Umit
U
Department of Neurology, University of Wisconsin, Madison 53792, USA.
Osting
Susan
S
Hagen
Joshua
J
Rutecki
Paul
P
Sutula
Thomas
T
D000818:Animals; D001369:Axons / Q000502:physiology*; D002352:Carrier Proteins / Q000032:analysis; D002478:Cells, Cultured; D002766:Cholecystokinin / Q000032:analysis; D018891:Dentate Gyrus / Q000166:cytology / Q000503:physiopathology*; D004827:Epilepsy / Q000209:etiology; D005071:Evoked Potentials; D050485:GABA Plasma Membrane Transport Proteins; D006801:Humans; D007395:Interneurons / Q000737:chemistry / Q000145:classification; D007696:Kindling, Neurologic; D007700:Kinetics; D008297:Male; D008565:Membrane Proteins / Q000032:analysis; D026901:Membrane Transport Proteins; D009433:Neural Inhibition; D027361:Organic Anion Transporters; D018408:Patch-Clamp Techniques; D051381:Rats; D017207:Rats, Sprague-Dawley; D012640:Seizures / Q000209:etiology* / Q000503:physiopathology
D002352:Carrier Proteins; D050485:GABA Plasma Membrane Transport Proteins; D008565:Membrane Proteins; D026901:Membrane Transport Proteins; D027361:Organic Anion Transporters; C493413:SLC6A1 protein, human; C493415:Slc6a1 protein, rat; D002766:Cholecystokinin